covaxin vaccine news

New Delhi: A single-dose of Covaxin provides a similar immunity response in previously Covid-infected people as those without previous history of Covid infection with two doses of vaccine, says Indian Council of Medical Research's latest…
Read More...

New Delhi: The trials of Bharat Biotech's covid-19 vaccine, Covaxin, on children are underway. The results are expected by September, said AIIMS director Randeep Guleria. According to sources, the second dose of Covaxin trials is likely…
Read More...

New Delhi: The supply price of Covaxin to the government of India at Rs 150 a dose is a non-competitive price and clearly not sustainable in the long run. Hence a higher price in private markets is required to offset part of the costs,…
Read More...

New Delhi: The All India Institute of Medical Sciences (AIIMS) is learnt to have started screening of children aged 6-12 years for the clinical trials of India's first indigenously developed Covid-19 vaccine, Bharat Biotech's Covaxin.…
Read More...

Bhubaneswar: Bharat Biotech’s Covaxin that aims to protect against COVID-19, has arrived in Bhubaneswar today. As many as 53,270 doses of Covaxin vaccine has reached at the Biju Patnaik International Airport (BPIA). Reportedly, these…
Read More...

New Delhi: The screening of children for clinical trials of Covaxin has begun on Monday at All India Institute of Medical Science (AIIMS) in Delhi. Similar trials has also started at AIIMS in Patna. The AIIMS, Delhi is conducting the…
Read More...

New Delhi: Amid the Covid vaccine shortage in the country during the ongoing vaccination drive, Bharat Biotech has dispatched its vaccine to 30 cities in a month, informed Co-Founder & Joint Managing Director Suchitra Ella. "COVAXIN…
Read More...

New Delhi: Indians who have been inoculated with Covaxin jabs manufactured by Bharat Biotech may not be able to travel abroad as and when the countries roll out their travel policies as it has not been listed under the World Health…
Read More...

New Delhi: Clinical trials to test Covaxin vaccine's efficacy in children between two to 18 years of age will begin in 10-12 days, top officials said on Tuesday. Addressing the Union Health Ministry press conference, NITI Aayog's Member…
Read More...

New Delhi: Bharat Biotech's Covid-19 vaccine Covaxin got approved by an expert panel on Tuesday for phase II and III human clinical trials on those between 2-18 years of age. The Subject Expert Committee (SEC) on Covid-19 of the Central…
Read More...